Cargando…

Exogenous carbon monoxide protects against mitochondrial DNA-induced hippocampal pyroptosis in a model of hemorrhagic shock and resuscitation

Carbon monoxide-releasing molecule-3 (CORM-3), which is an exogenous carbon monoxide (CO) compound, slowly releases CO under physiological conditions; this exerts neuroprotective effects against incomplete ischemia/reperfusion injury. The objective of the present study was to investigate whether the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Lan, Zhang, Dong-Xue, Zhang, Li-Min, Song, Yan-Cheng, Liu, Feng-Hai, Li, Yan, Wang, Xu-Peng, Zheng, Wei-Chao, Wang, Xiao-Dong, Gui, Chun-Xiao, Kong, Xiang-Jun, Kang, Li-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053849/
https://www.ncbi.nlm.nih.gov/pubmed/32124959
http://dx.doi.org/10.3892/ijmm.2020.4493
Descripción
Sumario:Carbon monoxide-releasing molecule-3 (CORM-3), which is an exogenous carbon monoxide (CO) compound, slowly releases CO under physiological conditions; this exerts neuroprotective effects against incomplete ischemia/reperfusion injury. The objective of the present study was to investigate whether the administration of CORM-3 protects against nucleotide-binding oligomerization domain-like receptor pyrin domain-3 (NLRP3) inflammasome formation and neuronal pyroptosis in the hippocampus following hemorrhagic shock and resuscitation (HSR). To establish this, an HSR model was created. Hemorrhagic shock was induced in adult male Sprague-Dawley rats under sevoflurane anesthesia by bleeding using a heparinized syringe to maintain a mean arterial pressure of 30±5 mmHg for 60 min. Resuscitation was performed by reperfusion of the blood and, if necessary, administering sterile saline to achieve the baseline arterial pressure. Following resuscitation, CORM-3 (4 mg/kg) was injected via the femoral vein. Neuronal pyroptosis in the hippocampus, mitochondrial morphology, mitochondrial DNA (mtDNA), brain magnetic resonance imaging, expression levels of NLRP3 and the interaction of pro-caspase-1 and apoptosis-associated speck-like protein containing a CARD domain (ASC) were examined 12 h after HSR; locomotor activity was assessed 7 days after HSR. Compared with HSR-treated rats, CORM-3 administration resulted in a lower level of neuronal pyroptosis in the hippocampus, improved mitochondrial morphology, a lower mtDNA level, steadier levels of metabolites, decreased expression levels of NLRP3 and pro-caspase-1 interacting with ASC and enhanced locomotor activity. In conclusion, treatment with CORM-3 ameliorated impairments of locomotor and exploratory activities in a rat model of HSR. The mechanism may be associated with the inhibition of mitochondrial DNA-induced pyroptosis via improvements in cell metabolism.